Dealert› Deals› Pharmakina

AlphaTalents Africa → Pharmakina

Management Buyout / Buy-In (MBO) Democratic Republic of the Congo Biopharmaceuticals Other / Unspecified
Deal summary

Information on the target

AlphaTalents Africa (ATA) has acquired a controlling stake in Pharmakina, a prominent pharmaceutical company based in the Democratic Republic of Congo (DRC). Pharmakina is a well-established household name in the DRC, recognized for its production of quinine-based ingredients and anti-malarial drugs for over 75 years. The company operates one of the few quinine extraction and processing plants in Africa, delivering more than 10 million malarial cures annually.

Headquartered in the fertile South Kivu province, Pharmakina stands as Africa's leading producer of quinine, a vital substance derived from the bark of the cinchona tree, historically used to treat malaria since the early 19th century. Beyond its medicinal applications, quinine also finds use in the cosmetics and food and beverage industries globally.

Industry overview in the target’s specific country

The Democratic Republic of Congo is increasingly recognized as a developing investment ecosystem with significant potential for impact. Historically viewed as a region of extremes—high risks and opportunities—the DRC has often deterred investors, particularly outside the mining sector. However, recent government efforts have focused on stabilizing the economy, resulting in an increase in foreign exchange reserves to approximately US$4 billion by mid-2022.

Economic observers note that the DRC has effectively 'dollarized', mitigating foreign exchange risks that have traditionally plagued foreign investors. This shift has led to a notable increase in Foreign Direct Investment (FDI), which rose from US$1.3 billion in 2003 to US$25.6 billion in 2019, primarily driven by investments in mining and telecommunications. More recently, the DRC has attracted greenfield investments in renewable energy and agri-processing sectors.

As the DRC continues to evolve, investments in impactful companies like Pharmakina are well-positioned to align with investor expectations for human, social, environmental, and financial returns. The region is witnessing a growing presence of international corporations, with established entities such as Hilton and DP World setting up local operations, while existing players like Accor and Orange expand their footprint.

With a population of nearly 101 million in 2022, over 53% of whom are under 18, the DRC presents vast untapped market potential. The capital city, Kinshasa, boasts a population exceeding 15 million, surpassing many other Afr…

This is a public preview. The full deal page — disclosed financials, full description, advisers, comparable set — is available with a free account.
Create free account
View primary source ↗